Project Grant R33AG102584
- The National Institute on Aging awarded Education Development Center, Inc. $320,150 under the Aging Research program (CFDA 93.866) on September 1, 2026. The research project examines elder mistreatment and self-neglect among older adults with Alzheimer's disease and related dementias, leveraging the UCLA Alzheimer's and Dementia Care (ADC) Program's longitudinal dataset of structured data and clinical notes from dementia care specialists. The study expands the existing dataset to include three...
- The National Institutes of Health's National Institute on Aging awarded $256,331.40 under the Aging Research program (CFDA 93.866) to The Trustees of the University of Pennsylvania from February to October 2021. The project aims to develop novel machine learning algorithms and biomedical software to more accurately quantify brain aging and predict the onset of neurodegenerative diseases such as Alzheimer's. Specifically, the funding will support refining predictive models of the...
- The National Institute on Aging awarded the University of Maryland, Baltimore $531,898 under the Aging Research program (CFDA 93.866) on September 20, 2025, to develop and deliver the Entrepreneurship & Science Communication for Aging and Aging-Related Research (ESCAAR) program, a skills-training initiative for doctoral students and postdoctoral scholars in aging and aging-related diseases. The program trains early-career researchers to communicate research impact effectively to public...
- The National Institute on Aging awarded the National Bureau of Economic Research Inc. $427,646 on September 1, 2026, under the Aging Research program (CFDA 93.866) to trace mid-life mortality of birth cohorts born approximately 1940–1960 in the United States by place, time, and family factors. The research combines large-scale administrative datasets—the Numident, Bureau of the Census Numident Mortality Detail file, and Mortality Linkage Project data, containing more than 3.5 million death...
- The National Institute on Aging awarded the University of California, Los Angeles $623,176 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research on modifiable risk factors for Alzheimer's disease and related dementias among individuals aged 90 and older. The research triangulates evidence across four data sources—the LifeAfter90 Study (1,397 participants, all aged 90), the 90+ Study (1,630 participants, all aged 90), the Health and Retirement Study (3,359...
- The National Institute on Aging awarded New York University $6.203 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to examine peripheral immune markers and vascular dysfunction as contributors to cognitive decline and Alzheimer's disease. The research integrates circulating biomarkers—platelet aggregation, neutrophil activity, and proteomic data—with advanced imaging to assess associations between vascular and immune dysfunction and cerebrovascular burden, amyloid...
- The National Institute on Aging awarded the University of Pennsylvania $150,104 on March 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research investigating the role of social relationships in dementia risk among older individuals with traumatic brain injury and among their spouses serving as caregivers. The research examines how interpersonal factors and social engagement modify the association between traumatic brain injury and risk of Alzheimer's disease and related...
- The National Institute on Aging awarded Northwestern University $1,341,808 on February 15, 2026, under the Aging Research program (CFDA 93.866) to conduct longitudinal research on aging-in-place and long-term care decision-making among older adults with Alzheimer's dementia. The research extends a current cohort study (R01AG058777) of 293 older adults with a 94.5 percent retention rate. Northwestern will follow subjects every six months through 42 months with surveys examining how aging-in-place...
- The National Institute on Aging awarded the Regents of the University of Michigan $116,079 on September 1, 2026, under the Aging Research program (CFDA 93.866) to assess how multilevel life course socioeconomic conditions relate to disparities in Alzheimer's disease and related dementias. The project examines socioeconomic trajectories at both individual and neighborhood levels in relation to cognitive decline, dementia incidence, and brain health indicators including structural magnetic...
- The National Institute on Aging awarded the University of California Irvine $5,101,916 on July 1, 2026, under the Aging Research program (CFDA 93.866) to examine daily dynamics of social connection and their influence on physical and cognitive functioning across the adult lifespan. The research uses longitudinal daily diary datasets from the Midlife in the United States Study (MIDUS), including four waves of diary data across approximately 20 years (beginning in 2002, 2014, and 2023) and two...
The National Institute on Aging awarded the University of Maryland, College Park $568,481 on September 1, 2026, under the Aging Research program (CFDA 93.866) to advance research on early-life determinants, biosocial pathways, and dementia through the Network on Early-Life Determinants, Biosocial Pathways, and Dementia (EDDEM). The award funds multidisciplinary research collaborations that examine how early-life conditions shape dementia risk through social, behavioral, and biological pathways, expanding beyond prior work focused on education to encompass a wider range of early-life exposures. The funding establishes a data resource and sharing hub that provides consultation on study design and data management, reviews analytic code for accuracy and reproducibility, and maintains a curated online catalogue of analytic resources to strengthen rigor and transparency in accessing and using NIH-supported longitudinal population datasets that include early-life measures, biomarkers, and cognitive assessments. The award also expands research capacity and infrastructure to engage new investigators and disciplines through innovative initiatives and shared resources that accelerate discovery, and builds new partnerships with NIA-supported aging centers to extend the network's reach and strengthen long-term sustainability. Performance takes place in College Park, Maryland. The period of performance runs from September 1, 2026, through August 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $568.5k | 8/25/26 |